ACG
ABBV icon

Allen Capital Group’s AbbVie ABBV Stock Holding History

Allen Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$985K Buy
3,915
+108
+3% +$23.2K 0.08% 145
2026
Q1 		$828K Buy
3,807
+409
+12% +$90.7K 0.07% 144
2025
Q4 		$776K Buy
3,398
+203
+6% +$46.2K 0.07% 151
2025
Q3 		$740K Sell
3,195
-22
-0.7% -$4.48K 0.07% 152
2025
Q2 		$597K Buy
3,217
+348
+12% +$64.7K 0.06% 164
2025
Q1 		$601K Buy
2,869
+91
+3% +$17.7K 0.07% 143
2024
Q4 		$494K Buy
2,778
+337
+14% +$62K 0.06% 152
2024
Q3 		$482K Buy
2,441
+279
+13% +$52.1K 0.06% 146
2024
Q2 		$371K Buy
2,162
+197
+10% +$32.6K 0.05% 149
2024
Q1 		$358K Buy
1,965
+361
+23% +$62.2K 0.05% 147
2023
Q4 		$249K Buy
+1,604
New +$234K 0.04% 157

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Allen Capital Group's ABBV Position: Q2 2026 in Review

Allen Capital Group increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $23.2K and bringing the position to 3,915 shares worth $985K. The position accounts for 0.08% of the portfolio, ranked #145.

Allen Capital Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Allen Capital Group held 3,915 shares of AbbVie worth $985K as of Q2 2026.
  • Allen Capital Group bought 108 AbbVie shares in Q2 2026, an estimated $23.2K.
  • AbbVie made up 0.08% of Allen Capital Group's portfolio in Q2 2026, its #145 holding.
  • Allen Capital Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allen Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.